E

Embera NeuroTherapeutics

5 employees

Embera NeuroTherapeutics is a development-stage pharmaceutical company developing treatments for smoking cessation and other addictions.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Therapeutics
Medical Device

Date founded

2005

Funding rounds raised

Total raised

$11M

from 10 investors over 10 rounds

E

Embera NeuroTherapeutics raised $1.3M on February 12, 2021

Investors: Innovation Catalyst

E

Embera NeuroTherapeutics raised undisclosed on September 11, 2020

Investors: Keiretsu Capital

E

Embera NeuroTherapeutics raised $4.4M on December 19, 2019

Investors: Keiretsu Capital

E

Embera NeuroTherapeutics raised undisclosed on December 19, 2019

Investors: The National Institute on Drug Abuse (NIDA)

E

Embera NeuroTherapeutics raised undisclosed on August 18, 2016

Investors: Keiretsu Capital

E

Embera NeuroTherapeutics raised $11M on July 26, 2016

Investors: National Institutes of Health and Keiretsu Capital

E

Embera NeuroTherapeutics raised undisclosed on May 26, 2016

Investors: Keiretsu Capital

E

Embera NeuroTherapeutics raised undisclosed on January 29, 2016

Investors: Keiretsu Capital

E

Embera NeuroTherapeutics raised $2M on September 11, 2015

Investors: Keiretsu Capital

FAQ